aTyr Pharma, Inc. (FRA:471A)

aTyr Pharma Statistics

Total Valuation

aTyr Pharma has a market cap or net worth of EUR 65.96 million. The enterprise value is -1.34 million.

Market Cap	65.96M
Enterprise Value	-1.34M

Important Dates

The next estimated earnings date is Monday, March 16, 2026.

Earnings Date	Mar 16, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	97.99M
Shares Outstanding	n/a
Shares Change (YoY)	+30.37%
Shares Change (QoQ)	+7.80%
Owned by Insiders (%)	2.49%
Owned by Institutions (%)	62.29%
Float	95.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	407.29
PB Ratio	0.97
P/TBV Ratio	0.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.02
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.02

Financial Position

The company has a current ratio of 5.93, with a Debt / Equity ratio of 0.15.

Current Ratio	5.93
Quick Ratio	5.82
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	-0.20
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -103.49% and return on invested capital (ROIC) is -57.46%.

Return on Equity (ROE)	-103.49%
Return on Assets (ROA)	-49.59%
Return on Invested Capital (ROIC)	-57.46%
Return on Capital Employed (ROCE)	-86.45%
Revenue Per Employee	2,655
Profits Per Employee	-1.05M
Employee Count	65
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.45% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-81.45%
50-Day Moving Average	0.67
200-Day Moving Average	3.00
Relative Strength Index (RSI)	43.74
Average Volume (20 Days)	450

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.71

Income Statement

In the last 12 months, aTyr Pharma had revenue of EUR 161,937 and -64.03 million in losses. Loss per share was -0.72.

Revenue	161,937
Gross Profit	-52.30M
Operating Income	-67.03M
Pretax Income	-64.03M
Net Income	-64.03M
EBITDA	-66.46M
EBIT	-67.03M
Loss Per Share	-0.72

Balance Sheet

The company has 76.88 million in cash and 10.53 million in debt, giving a net cash position of 66.35 million.

Cash & Cash Equivalents	76.88M
Total Debt	10.53M
Net Cash	66.35M
Net Cash Per Share	n/a
Equity (Book Value)	68.22M
Book Value Per Share	0.70
Working Capital	65.91M

Cash Flow

In the last 12 months, operating cash flow was -53.63 million and capital expenditures -60,513, giving a free cash flow of -53.69 million.

Operating Cash Flow	-53.63M
Capital Expenditures	-60,513
Free Cash Flow	-53.69M
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-41,395.26%
Pretax Margin	-39,540.53%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

aTyr Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.37%
Shareholder Yield	-30.37%
Earnings Yield	-97.08%
FCF Yield	-81.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 1, 2019. It was a reverse split with a ratio of 0.0714285714.

Last Split Date	Jul 1, 2019
Split Type	Reverse
Split Ratio	0.0714285714

Scores

aTyr Pharma has an Altman Z-Score of -1.84 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.84
Piotroski F-Score	2